accutarbio.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $207.47MM
AccutarBio is a biotechnology company employing artificial intelligence to revolutionize drug discovery.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/20/2021 | Series B+4 | $80MM | $xx.xx | $987.52MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,031,206
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
04/18/2021 | Series B+3 | $10MM | $xx.xx | $460.71MM | Yunfeng Capital, Coatue, 3W Healthcare Fund, ZhenFund, IDG Capital, YITU Technology, Primavera Capital Group, CDH Investments | |
Price per Share
$xx.xx
Shares Outstanding
244,910
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Yunfeng Capital, Coatue, 3W Healthcare Fund, ZhenFund, IDG Capital, YITU Technology, Primavera Capital Group, CDH Investments
|
||||||
12/21/2020 | Series B+2 | $20MM | $xx.xx | $430.04MM | Primavera Capital Group | |
Price per Share
$xx.xx
Shares Outstanding
551,754
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Primavera Capital Group
|
||||||
12/04/2020 | Series B+1 | $28.45MM | $xx.xx | $430.04MM | Primavera Capital Group | |
Price per Share
$xx.xx
Shares Outstanding
860,735
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Primavera Capital Group
|
||||||
08/31/2020 | Series B+ | $26.66MM | $xx.xx | $267.18MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,020,422
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
07/11/2019 | Series B | $25MM | $xx.xx | $190.78MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,191,654
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
12/06/2017 | Series A-3 | $12.3MM | $xx.xx | $98.81MM | IDG Capital, Yitu Technology | |
Price per Share
$xx.xx
Shares Outstanding
1,031,601
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
IDG Capital, Yitu Technology
|
||||||
12/06/2017 | Series A-2 | $3MM | $xx.xx | $98.81MM | IDG Capital, Yitu Technology | |
Price per Share
$xx.xx
Shares Outstanding
754,830
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
IDG Capital, Yitu Technology
|
||||||
12/06/2017 | Series A-1 | $2.05MM | $xx.xx | $98.81MM | IDG Capital, Yitu Technology | |
Price per Share
$xx.xx
Shares Outstanding
1,114,130
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
IDG Capital, Yitu Technology
|